Narendra Vyavahare - Publications

Bioengineering Clemson University, Clemson, SC, United States 

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Simpson CL, Mosier JA, Vyavahare NR. Osteoclast-Mediated Cell Therapy as an Attempt to Treat Elastin Specific Vascular Calcification. Molecules (Basel, Switzerland). 26. PMID 34203711 DOI: 10.3390/molecules26123643  0.639
2017 Tam H, Zhang W, Infante D, Parchment N, Sacks M, Vyavahare N. Fixation of Bovine Pericardium-Based Tissue Biomaterial with Irreversible Chemistry Improves Biochemical and Biomechanical Properties. Journal of Cardiovascular Translational Research. PMID 28213846 DOI: 10.1007/S12265-017-9733-5  0.384
2016 Nosoudi N, Chowdhury A, Siclari S, Karamched S, Parasaram V, Parrish J, Gerard P, Vyavahare N. Reversal of Vascular Calcification and Aneurysms in a Rat Model Using Dual Targeted Therapy with EDTA- and PGG-Loaded Nanoparticles. Theranostics. 6: 1975-1987. PMID 27698934 DOI: 10.7150/Thno.16547  0.385
2015 Nosoudi N, Nahar-Gohad P, Sinha A, Chowdhury A, Gerard P, Carsten CG, Gray BH, Vyavahare NR. Prevention of Abdominal Aortic Aneurysm Progression by Targeted Inhibition of Matrix Metalloproteinase Activity With Batimastat-Loaded Nanoparticles. Circulation Research. 117: e80-9. PMID 26443597 DOI: 10.1161/Circresaha.115.307207  0.502
2015 Tam H, Zhang W, Feaver KR, Parchment N, Sacks MS, Vyavahare N. A novel crosslinking method for improved tear resistance and biocompatibility of tissue based biomaterials. Biomaterials. 66: 83-91. PMID 26196535 DOI: 10.1016/J.Biomaterials.2015.07.011  0.421
2015 Simmers P, Gishto A, Vyavahare N, Kothapalli CR. Nitric oxide stimulates matrix synthesis and deposition by adult human aortic smooth muscle cells within three-dimensional cocultures. Tissue Engineering. Part A. 21: 1455-70. PMID 25597545 DOI: 10.1089/Ten.Tea.2014.0363  0.463
2014 Lei Y, Nosoudi N, Vyavahare N. Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects. Journal of Controlled Release : Official Journal of the Controlled Release Society. 196: 79-86. PMID 25285609 DOI: 10.1016/J.Jconrel.2014.09.029  0.374
2014 Sinha A, Shaporev A, Nosoudi N, Lei Y, Vertegel A, Lessner S, Vyavahare N. Nanoparticle targeting to diseased vasculature for imaging and therapy. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 1003-12. PMID 24566276 DOI: 10.1016/J.Nano.2014.02.002  0.582
2014 Lei Y, Sinha A, Nosoudi N, Grover A, Vyavahare N. Hydroxyapatite and calcified elastin induce osteoblast-like differentiation in rat aortic smooth muscle cells. Experimental Cell Research. 323: 198-208. PMID 24447384 DOI: 10.1016/J.Yexcr.2014.01.011  0.622
2014 Sinha A, Nosoudi N, Vyavahare N. Elasto-regenerative properties of polyphenols. Biochemical and Biophysical Research Communications. 444: 205-11. PMID 24440697 DOI: 10.1016/J.Bbrc.2014.01.027  0.549
2014 Tripi DR, Vyavahare NR. Neomycin and pentagalloyl glucose enhanced cross-linking for elastin and glycosaminoglycans preservation in bioprosthetic heart valves Journal of Biomaterials Applications. 28: 757-766. PMID 24371208 DOI: 10.1177/0885328213479047  0.396
2013 Lei Y, Grover A, Sinha A, Vyavahare N. Efficacy of reversal of aortic calcification by chelating agents. Calcified Tissue International. 93: 426-35. PMID 23963635 DOI: 10.1007/S00223-013-9780-0  0.639
2013 Sinha A, Vyavahare NR. High-glucose levels and elastin degradation products accelerate osteogenesis in vascular smooth muscle cells. Diabetes & Vascular Disease Research. 10: 410-9. PMID 23754846 DOI: 10.1177/1479164113485101  0.475
2013 Eckert CE, Fan R, Mikulis B, Barron M, Carruthers CA, Friebe VM, Vyavahare NR, Sacks MS. On the biomechanical role of glycosaminoglycans in the aortic heart valve leaflet. Acta Biomaterialia. 9: 4653-60. PMID 23036945 DOI: 10.1016/J.Actbio.2012.09.031  0.302
2013 Leong J, Munnelly A, Liberio B, Cochrane L, Vyavahare N. Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves. Journal of Biomaterials Applications. 27: 948-60. PMID 22207605 DOI: 10.1177/0885328211430542  0.395
2012 Munnelly AE, Cochrane L, Leong J, Vyavahare NR. Porcine vena cava as an alternative to bovine pericardium in bioprosthetic percutaneous heart valves. Biomaterials. 33: 1-8. PMID 21993239 DOI: 10.1016/j.biomaterials.2011.09.027  0.43
2012 Munnelly A, Schoen F, Vyavahare N. Biomaterial calcification: Mechanisms and prevention Degradation of Implant Materials. 359-392. DOI: 10.1007/978-1-4614-3942-4_14  0.312
2011 Friebe VM, Mikulis B, Kole S, Ruffing CS, Sacks MS, Vyavahare NR. Neomycin enhances extracellular matrix stability of glutaraldehyde crosslinked bioprosthetic heart valves. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 99: 217-29. PMID 21714085 DOI: 10.1002/Jbm.B.31889  0.453
2011 Kurane A, Vyavahare N. Endothelial cells seeded on elastin-heparin matrices express normal EC markers and resist detachment on exposure to shear stress: A histological study Journal of Histotechnology. 34: 11-19. DOI: 10.1179/014788811X12949268296004  0.76
2010 Raghavan D, Shah SR, Vyavahare NR. Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 92: 168-77. PMID 19810110 DOI: 10.1002/Jbm.B.31503  0.586
2009 Kurane A, Vyavahare N. In vivo vascular tissue engineering: influence of cytokine and implant location on tissue specific cellular recruitment. Journal of Tissue Engineering and Regenerative Medicine. 3: 280-9. PMID 19283727 DOI: 10.1002/Term.164  0.788
2009 Raghavan D, Starcher BC, Vyavahare NR. Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage. Acta Biomaterialia. 5: 983-92. PMID 19091637 DOI: 10.1016/J.Actbio.2008.11.004  0.671
2008 Shah SR, Vyavahare NR. The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves Biomaterials. 29: 1645-1653. PMID 18199477 DOI: 10.1016/j.biomaterials.2007.12.009  0.392
2007 Kutty JK, Cho E, Soo Lee J, Vyavahare NR, Webb K. The effect of hyaluronic acid incorporation on fibroblast spreading and proliferation within PEG-diacrylate based semi-interpenetrating networks. Biomaterials. 28: 4928-38. PMID 17720239 DOI: 10.1016/J.Biomaterials.2007.08.007  0.305
2007 Kurane A, Simionescu DT, Vyavahare NR. In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor. Biomaterials. 28: 2830-8. PMID 17368531 DOI: 10.1016/J.Biomaterials.2007.02.031  0.78
2007 Raghavan D, Simionescu DT, Vyavahare NR. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials. 28: 2861-8. PMID 17353047 DOI: 10.1016/J.Biomaterials.2007.02.017  0.636
2007 Simpson CL, Lindley S, Eisenberg C, Basalyga DM, Starcher BC, Simionescu DT, Vyavahare NR. Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 16: 29-37. PMID 17218212 DOI: 10.1016/J.Carpath.2006.07.001  0.758
2007 Sellaro TL, Hildebrand D, Lu Q, Vyavahare N, Scott M, Sacks MS. Effects of collagen fiber orientation on the response of biologically derived soft tissue biomaterials to cyclic loading. Journal of Biomedical Materials Research. Part A. 80: 194-205. PMID 17041913 DOI: 10.1002/Jbm.A.30871  0.568
2007 Mercuri JJ, Lovekamp JJ, Simionescu DT, Vyavahare NR. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization. Biomaterials. 28: 496-503. PMID 17030363 DOI: 10.1016/J.Biomaterials.2006.09.005  0.8
2006 Isenburg JC, Karamchandani NV, Simionescu DT, Vyavahare NR. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials. 27: 3645-51. PMID 16527345 DOI: 10.1016/j.biomaterials.2006.02.016  0.314
2006 Lee JS, Basalyga DM, Simionescu A, Isenburg JC, Simionescu DT, Vyavahare NR. Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. The American Journal of Pathology. 168: 490-8. PMID 16436663 DOI: 10.2353/Ajpath.2006.050338  0.783
2006 Lovekamp JJ, Simionescu DT, Mercuri JJ, Zubiate B, Sacks MS, Vyavahare NR. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials. 27: 1507-18. PMID 16144707 DOI: 10.1016/J.Biomaterials.2005.08.003  0.804
2006 Simionescu DT, Lu Q, Song Y, Lee JS, Rosenbalm TN, Kelley C, Vyavahare NR. Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds. Biomaterials. 27: 702-13. PMID 16048731 DOI: 10.1016/J.Biomaterials.2005.06.013  0.684
2005 Lu Q, Simionescu A, Vyavahare N. Novel capillary channel fiber scaffolds for guided tissue engineering. Acta Biomaterialia. 1: 607-14. PMID 16701841 DOI: 10.1016/J.Actbio.2005.07.001  0.623
2005 Simionescu A, Philips K, Vyavahare N. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochemical and Biophysical Research Communications. 334: 524-32. PMID 16005428 DOI: 10.1016/J.Bbrc.2005.06.119  0.385
2005 Connolly JM, Alferiev I, Clark-Gruel JN, Eidelman N, Sacks M, Palmatory E, Kronsteiner A, Defelice S, Xu J, Ohri R, Narula N, Vyavahare N, Levy RJ. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms. The American Journal of Pathology. 166: 1-13. PMID 15631995 DOI: 10.1016/S0002-9440(10)62227-4  0.507
2005 Isenburg JC, Simionescu DT, Vyavahare NR. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials. 26: 1237-45. PMID 15475053 DOI: 10.1016/j.biomaterials.2004.04.034  0.419
2004 Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 110: 3480-7. PMID 15545515 DOI: 10.1161/01.Cir.0000148367.08413.E9  0.781
2004 Sun W, Sacks M, Fulchiero G, Lovekamp J, Vyavahare N, Scott M. Response of heterograft heart valve biomaterials to moderate cyclic loading Journal of Biomedical Materials Research - Part A. 69: 658-669. PMID 15162408 DOI: 10.1002/Jbm.A.30031  0.771
2004 Lu Q, Ganesan K, Simionescu DT, Vyavahare NR. Novel porous aortic elastin and collagen scaffolds for tissue engineering. Biomaterials. 25: 5227-37. PMID 15110474 DOI: 10.1016/J.Biomaterials.2003.12.019  0.668
2004 Bailey M, Pillarisetti S, Jones P, Xiao H, Simionescu D, Vyavahare N. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 13: 146-55. PMID 15081471 DOI: 10.1016/S1054-8807(04)00009-2  0.436
2004 Isenburg JC, Simionescu DT, Vyavahare NR. Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid. Biomaterials. 25: 3293-302. PMID 14980424 DOI: 10.1016/j.biomaterials.2003.10.001  0.405
2003 Simionescu DT, Lovekamp JJ, Vyavahare NR. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. Journal of Biomedical Materials Research. Part A. 66: 755-63. PMID 12926026 DOI: 10.1002/Jbm.A.10066  0.81
2003 Bailey MT, Pillarisetti S, Xiao H, Vyavahare NR. Role of elastin in pathologic calcification of xenograft heart valves Journal of Biomedical Materials Research - Part A. 66: 93-102. PMID 12833435  0.413
2003 Simionescu DT, Lovekamp JJ, Vyavahare NR. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. The Journal of Heart Valve Disease. 12: 226-34. PMID 12701796  0.812
2003 Simionescu DT, Lovekamp JJ, Vyavahare NR. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. The Journal of Heart Valve Disease. 12: 217-25. PMID 12701795  0.793
2003 Levy RJ, Vyavahare N, Ogle M, Ashworth P, Bianco R, Schoen FJ. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism. The Journal of Heart Valve Disease. 12: 209-16; discussion 2. PMID 12701794  0.344
2003 Caldwell RA, Vyavahare N, Langan EM, LaBerge M. Matrix metalloproteinase inhibitor within an absorbable coating for vascular applications: Delivery device characterization and the reduction of smooth muscle cell proliferation and migration Journal of Biomedical Materials Research - Part A. 67: 1-10. DOI: 10.1002/Jbm.A.10046  0.351
2001 Bailey M, Xiao H, Ogle M, Vyavahare N. Aluminum chloride pretreatment of elastin inhibits elastolysis by matrix metalloproteinases and leads to inhibition of elastin-oriented calcification American Journal of Pathology. 159: 1981-1986. PMID 11733347  0.36
2001 Alferiev I, Vyavahare N, Song C, Connolly J, Travis Hinson J, Lu Z, Tallapragada S, Bianco R, Levy R. Bisphosphonate derivatized polyurethanes resist calcification Biomaterials. 22: 2683-2693. PMID 11519788 DOI: 10.1016/S0142-9612(01)00010-2  0.406
2001 Lovekamp J, Vyavahare N. Periodate-mediated glycosaminoglycan stabilization in bioprosthetic heart valves Journal of Biomedical Materials Research. 56: 478-486. PMID 11400125 DOI: 10.1002/1097-4636(20010915)56:4<478::Aid-Jbm1119>3.0.Co;2-C  0.801
2000 Vyavahare N, Jones PL, Tallapragada S, Levy RJ. Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats American Journal of Pathology. 157: 885-893. PMID 10980128 DOI: 10.1016/S0002-9440(10)64602-0  0.445
2000 Lovekamp J, Vyavahare N. Improved extracellular matrix stabilization of bioprosthetic heart valves Annals of Biomedical Engineering. 28: S-4.  0.382
1999 Vyavahare N, Ogle M, Schoen FJ, Levy RJ. Elastin calcification and its prevention with aluminum chloride pretreatment American Journal of Pathology. 155: 973-982. PMID 10487855 DOI: 10.1016/S0002-9440(10)65197-8  0.356
1999 Mohler ER, Chawla MK, Chang AW, Vyavahare N, Levy RJ, Graham L, Gannon FH. Identification and characterization of calcifying valve cells from human and canine aortic valves Journal of Heart Valve Disease. 8: 254-260. PMID 10399657  0.356
1999 Vyavahare N, Ogle M, Schoen FJ, Zand R, Gloeckner DC, Sacks M, Levy RJ. Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. Journal of Biomedical Materials Research. 46: 44-50. PMID 10357134 DOI: 10.1002/(Sici)1097-4636(199907)46:1<44::Aid-Jbm5>3.0.Co;2-D  0.465
1999 Vyavahare N, Ogle M, Schoen FJ, Levy RJ. Mechanisms of elastin calcification and its prevention with aluminum chloride pretreatment Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 2: 760.  0.339
1997 Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R, Kruth HS, Zand R, Levy RJ. Prevention of bioprosthetic heart valve calcification by ethanol preincubation: Efficacy and mechanisms Circulation. 95: 479-488. PMID 9008467 DOI: 10.1161/01.Cir.95.2.479  0.404
1997 Vyavahare NR, Chen W, Joshi RR, Lee CH, Hirsch D, Levy J, Schoen FJ, Levy RJ. Current progress in anticalcification for bioprosthetic and polymeric heart valves Cardiovascular Pathology. 6: 219-229. DOI: 10.1016/S1054-8807(97)00017-3  0.411
1996 Levy RJ, Vyavahare N, Joshi R, Chen W, Hirsch D, Levy J, Schoen F. Current progress in anti-calcification and alternative fixation methodology for bioprosthetic valves Cardiovascular Pathology. 5: 291. DOI: 10.1016/1054-8807(96)80371-1  0.343
1995 Levy RJ, Labhasetwar V, Song C, Lerner E, Chen W, Vyavahare N, Qu X. Polymeric drug delivery systems for treatment of cardiovascular calcification, arrhythmias and restenosis Journal of Controlled Release. 36: 137-147. DOI: 10.1016/0168-3659(95)00045-A  0.337
1995 Vyavahare NR, Qu X, Lee M, Behari P, Schoen FJ, Levy RJ. Synergism of calcium-ethanehydroxybisphosphonate (CaEHBP) and FeC13: controlled release polymers for preventing calcification of bioprosthetic aortic wall Journal of Controlled Release. 34: 97-108. DOI: 10.1016/0168-3659(94)00130-M  0.316
Show low-probability matches.